US Patent Issued to EDGEWISE THERAPEUTICS on Dec. 30 for "1,4-dihydroquinazolinone compounds and uses thereof" (Colorado, Washington, Connecticut, California Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,431, issued on Dec. 30, was assigned to EDGEWISE THERAPEUTICS INC. (Boulder, Colo.).

"1,4-dihydroquinazolinone compounds and uses thereof" was invented by Natalie Anne Hawryluk (Nederland, Colo.), Stephen Thomas Schlachter (Boulder, Colo.), Marc Justin Evanchik (Boulder, Colo.), Carlos Luis Del Rio (San Mateo, Calif.), Alan James Russell (Boulder, Colo.), Kevin Koch (Niwot, Colo.), Michael Mark DuVall (Vancouver, Wash.), Michael Joseph Luzzio (Groton, Conn.) and Kevin Hunt (Boulder, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided dihydroquinazolinone and azadihydroquinazolinone compounds for treating cardiac indications such as hypertr...